课题基金 / 基金详情

Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity

Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity
开发一种更安全的系统性红斑狼疮新疗法,可保留 B 细胞免疫
批准号:
nhmrc : 1113659
负责人:
Prof Fabienne Mackay
金额:
$46.1万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Development Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 2018-12-31

项目摘要

项目成果

Prof Fabienne Mackay的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lupus is an illness characterized by the body’s immune system attacking the body itself. More than 5 millions of people worldwide suffer from lupus, in particular Indigenous Australians who are 4 times more likely to develop lupus. Current treatments are toxic and/or lack efficacy. In this proposal we use strong new evidence from the laboratory to support the design of a much safer and more effective treatment for lupus that will be validated for future use in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity
  • 批准号:
    nhmrc : GNT1113659
  • 项目类别:
    Development Grants
  • 资助金额:
    $67.2万
  • 财政年份:
    2016
  • 负责人:
    Prof Fabienne Mackay
  • 依托单位:
Research Fellowship
  • 批准号:
    nhmrc : 1020630
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $45.06万
  • 财政年份:
    2012
  • 负责人:
    Prof Fabienne Mackay
  • 依托单位:
The role of BAFF, its receptor TACI and Toll-like receptors in Autoimmunity and Tolerance.
  • 批准号:
    nhmrc : 1008520
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $32.46万
  • 财政年份:
    2011
  • 负责人:
    Prof Fabienne Mackay
  • 依托单位:
Research Fellowship - Grant ID:427608
  • 批准号:
    nhmrc : 427608
  • 项目类别:
    NHMRC Research Fellowships
  • 资助金额:
    $41.26万
  • 财政年份:
    2007
  • 负责人:
    Prof Fabienne Mackay
  • 依托单位:
海外基金